CALCA and type 2 diabetes mellitus: Studies showed that adipose-derived stem cells (ASCs) in patients with type 2 diabetes mellitus (T2DM) caused upregulation of methylation level in promoter region of CALCA target fragment, resulting in a significant reduction in the osteogenic function of stem cells [35].